- Home
- ACR vs RAPT Comparison
ACR vs RAPT Comparison
Compare ACR & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- RAPT
- Stock Information
- Founded
- ACR 2005
- RAPT 2015
- Country
- ACR United States
- RAPT United States
- Employees
- ACR N/A
- RAPT N/A
- Industry
- ACR Real Estate Investment Trusts
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- ACR Real Estate
- RAPT Health Care
- Exchange
- ACR Nasdaq
- RAPT Nasdaq
- Market Cap
- ACR 139.0M
- RAPT 122.9M
- IPO Year
- ACR N/A
- RAPT 2019
- Fundamental
- Price
- ACR $19.26
- RAPT $10.49
- Analyst Decision
- ACR Buy
- RAPT Buy
- Analyst Count
- ACR 2
- RAPT 5
- Target Price
- ACR $17.50
- RAPT $32.20
- AVG Volume (30 Days)
- ACR 30.4K
- RAPT 100.1K
- Earning Date
- ACR 07-30-2025
- RAPT 08-11-2025
- Dividend Yield
- ACR N/A
- RAPT N/A
- EPS Growth
- ACR N/A
- RAPT N/A
- EPS
- ACR 0.34
- RAPT N/A
- Revenue
- ACR $83,545,000.00
- RAPT N/A
- Revenue This Year
- ACR $3.57
- RAPT N/A
- Revenue Next Year
- ACR N/A
- RAPT N/A
- P/E Ratio
- ACR $56.22
- RAPT N/A
- Revenue Growth
- ACR 6.92
- RAPT N/A
- 52 Week Low
- ACR $14.40
- RAPT $5.67
- 52 Week High
- ACR $23.81
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- ACR 61.49
- RAPT 50.12
- Support Level
- ACR $18.61
- RAPT $11.15
- Resistance Level
- ACR $19.22
- RAPT $13.50
- Average True Range (ATR)
- ACR 0.48
- RAPT 1.22
- MACD
- ACR 0.15
- RAPT -0.17
- Stochastic Oscillator
- ACR 80.23
- RAPT 28.71
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.